Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- London, England
- Most recent report
- 6-K, filed Oct 16, 2026
- Filings on record
- 488 filings
- On EDGAR
- CIK 1723069
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer
Financials 8 of 356
- 6-K Report a foreign issuer made public elsewhere Oct 16, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 16, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 30, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 28, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 21, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 17, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 24, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 6, 2026
Prospectuses and Registrations 8 of 26
- S-8 Registration statement for an employee plan Feb 20, 2026
- 424B5 Prospectus supplement for an offering Jan 22, 2026
- POS AM Post-effective amendment to a registration Jan 21, 2026
- 424B5 Prospectus supplement for an offering Jan 16, 2026
- 424B5 Prospectus supplement for an offering Dec 12, 2025
- FWP Free writing prospectus Dec 12, 2025
- F-3 Mar 24, 2025
- 424B5 Prospectus supplement for an offering Nov 1, 2024
Ownership 8 of 20
- 4 Insider reported a trade Sep 29, 2026
- 4/A Insider reported a trade, amended Aug 7, 2026
- 4/A Insider reported a trade, amended Aug 7, 2026
- 4 Insider reported a trade Aug 6, 2026
- 4 Insider reported a trade Aug 5, 2026
- 3 Insider reported their initial holding Jul 23, 2026
- 4 Insider reported a trade Jul 23, 2026
- 4 Insider reported a trade Jun 17, 2026
Other 8 of 86
Everything here comes from Tiziana Life Sciences Ltd's own filings on SEC EDGAR. The filing list is rechecked every hour.